Freenome, a biotechnology company pioneering an early cancer detection platform, has officially announced an exclusive license agreement with Exact Sciences to advance the commercialization...
Freenome, a biotechnology company pioneering an early cancer detection platform, has officially announced an exclusive license agreement with Exact Sciences to advance the commercialization...
Veracyte, Inc., a leading cancer diagnostics company, has officially presented new data at the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU), data which is...
The researching team at Children's Hospital of Philadelphia (CHOP) has officially announced the creation of a new AI technology called CelloType, which happens to...
